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Table 1  
 
Criteria and definition for the classification of cryopyrin-associated periodic 
syndrome (CAPS) 
Patient-related symptoms  
Family history of CAPS Phenotype and or genetic 
confirmation of CAPS in 
other family members 
Confirmed NLRP3 mutation Genetic confirmation of 
NLRP3 mutation 
CAPS disease course related variables  
Early disease onset Age at onset of CAPS 
typical symptoms in infancy 
or early childhood 
Episodic disease course characterized by CAPS 
typical symptoms with or without persistent 
inflammation  
Disease course with 
episodes of clinically active 
CAPS disease 
     Triggered inflammatory attacks  Triggers: cold or other   
stressors 
Evidence of raised inflammatory marker 
associated with CAPS clinical signs  
Evidence of CAPS clinical 
signs coupled with systemic 
inflammation, e.g. CRP 
CAPS typical symptoms  
     Amyloidosis Evidence of organ amyloid 
deposits, e.g. kidney 
Recurrent episodes of systemic symptoms  Evidence of systemic 
features like fever and/or 
chills and/or fatigue and/or 
rigors 
     Urticaria-like rash  Histologically characterized 
by neutrophilic dermatitis 
Chronic aseptic meningitis  Evidence of clinical, 
laboratory and/or imaging 
evidence of non infectious 
inflammatation of the 
meninges 
Recurrent eye inflammation,  Recurrent non-allergic, non-
infectious conjunctivitis 
with/without other 
inflammatory ocular 
manifestations 
Sensorineural hearing loss Evidence of increased 
hearing thresholds on 
audiogram 
Musculoskeletal sign and symptoms  Evidence of arthralgia, 
myalgia, arthritis and/or 
periarticular swelling 
Skeletal abnormalities  Evidence of epiphyseal 
overgrowth, frontal bossing, 
clubbing and/or growth 
failure 
 
 
 
 
 
 
 
 
 
 
 
Table 2  
Systematic literature review search items 
 
CAPS 
Pubmed 
“cryopyrin associated periodic syndromes”[MeSH Terms] OR 
“Cryopyrin Associated Periodic Syndromes”[tiab] OR “Cryopyrin 
Associated Periodic Syndrome”[tiab] OR “Cryopyrin Associated Periodic  
Fever Syndromes”[tiab] OR “Cryopyrin Associated Periodic Fever 
Syndrome”[tiab OR cryopyrinopath*[tiab] OR FCAS[tiab] OR “Familial 
Cold Autoinflammatory Syndrome”[tiab] OR “Familial Cold 
Urticaria”[tiab] OR MWS[tiab] OR “Muckle Wells Syndrome”[tiab] OR 
CINCA[tiab] OR (Chronic[tiab] AND Infantile[tiab] AND 
Neurological[tiab] AND Cutaneous[tiab] AND Articular[tiab]) OR 
NOMID[tiab] OR “Neonatal Onset Multisystem Inflammatory 
Disease”[tiab] OR “Infantile Onset Multisystem Inflammatory 
Disease”[tiab] 
1056 
CAPS 
Embase 
'cinca syndrome'/exp OR 'muckle wells syndrome'/exp OR 'familial cold 
autoinflammatory syndrome'/exp OR 'cryopyrin associated periodic 
syndromes':ab,ti OR 'cryopyrin associated periodic syndrome':ab,ti OR 
'cryopyrin associated periodic fever syndromes':ab,ti OR 'cryopyrin 
associated periodic fever syndrome':ab,ti OR cryopyrinopath*:ab,ti OR 
fcas:ab,ti OR 'familial cold autoinflammatory syndrome':ab,ti OR 
'familial cold urticaria':ab,ti OR mws:ab,ti OR 'muckle wells 
syndrome':ab,ti OR cinca:ab,ti OR (chronic:ab,ti AND infantile:ab,ti 
AND neurological:ab,ti AND cutaneous:ab,ti AND articular:ab,ti) OR 
nomid:ab,ti OR 'neonatal onset multisystem inflammatory 
disease':ab,ti OR 'infantile onset multisystem inflammatory 
disease':ab,ti 
1512 
CAPS 
 
MeSH descriptor: [Cryopyrin-Associated Periodic Syndromes] explode 
all trees OR 
"Cryopyrin Associated Periodic Syndromes" or "Cryopyrin Associated 
29 
  
 
  
Periodic Syndrome" or "Cryopyrin Associated Periodic Fever 
Syndromes" or "Cryopyrin Associated Periodic Fever Syndrome” or 
cryopyrinopath* or FCAS or "Familial Cold Autoinflammatory 
Syndrome" or "Familial Cold Urticaria" or MWS or "Muckle Wells 
Syndrome" or CINCA or (Chronic and Infantile and Neurological and 
Cutaneous and Articular) or NOMID or "Neonatal Onset Multisystem 
Inflammatory Disease" or "Infantile Onset Multisystem Inflammatory 
Disease"(title/abstract) 
AID 
Pubmed 
“Hereditary Autoinflammatory Diseases"[Mesh:NoExp] OR 
“autoinflammatory diseases”[tiab] OR “autoinflammatory 
syndromes”[tiab] OR “periodic fever syndromes”[tiab] OR 
“autoinflammatory disease”[tiab] OR “autoinflammatory 
syndrome”[tiab] OR “periodic fever syndrome”[tiab] 
781 (all) 
253[NtH1] 
(new) 
 
AID 
Embase 
'autoinflammatory disease'/de OR 'hereditary periodic fever'/de OR 
'autoinflammatory diseases':ab,ti OR 'autoinflammatory 
syndromes':ab,ti OR 'periodic fever syndromes':ab,ti OR 
'autoinflammatory disease':ab,ti OR 'autoinflammatory syndrome':ab,ti 
OR 'periodic fever syndrome':ab,ti 
1388 all 
508 
new[NtH2] 
AID 
Cochrane 
MeSH descriptor: [Hereditary Autoinflammatory Diseases] this term 
only 
OR  
"autoinflammatory diseases" or "autoinflammatory syndromes" or 
"periodic fever syndromes" or "autoinflammatory disease" or 
"autoinflammatory syndrome" or "periodic fever 
syndrome"(title/abstract) 
33 
Figure 1: Systematic literature review – search results 
 
 
 
 
 
Pubmed 
n=1056 
Embase 
n=1512 
Cochrane 
n =29 
1698 uniquearticles 
47 articles for full text 
screening 
33 articles for validity 
assessment 
Removingduplicates 
Excluded 
-no CAPS: 1013 
-no original or relevant 
data: 525 
-meeting abstracts: 71 
-case series<10pt: 41 
Excluded 
-no clinical CAPS features: 
13 
29 articles for 
recommendations 
Excluded 
-poor validity: 4 
Figure 2:  Correspondence analysis 
 
Results correspondence analysis
 
 
 
Correspondence analysis revealed three distinct entities: CAPS (red circle), non-CAPS 
autoinflammatory diseases (blue circle) and monophasic inflammatory diseases (green circle) 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Proposed CAPS diagnosis criteria model  
Raised inflammatory markers (CRP/SAA)
(Mandatory criteria) 
plus
≥ 2 of 6 CAPS typical signs/symptoms:
- urticaria-like rash
- cold/stress triggered episodes
- sensorineural hearing loss
- musculoskeletal symptoms( arthralgia/arthritis/myalgia)
- chronic aseptic meningitis
- skeletal abnormalities 
(epiphyseal overgrowth/frontal bossing
Step 6: Development of a diagnostic model
 
Legend . 
Specifity was 94%  and sensitivity was 81% for the CAPS diagnosis criteria model. It performed 
equally well for all CAPS subtypes and in subgroups with or without evidence of NLRP3 
mutation (p<0.001). 
 
  
 Figure 4 CAPS expert survey (supplemental material) 
 
Q1 Family History 
1. A positive family history of a genetically confirmed diagnosis of Cryopyrin-
Associated Periodic Syndrome (CAPS) in a family member 
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
This ranking applies to                   
all diseases in the CAPS spectrum OR 
only some diseases in the CAPS spectrum, please check all applicable 
 FCAS   FCAS/MWS   MWS  MWS/CINCA/NOMID   
CINCA/NOMID 
 
2. A positive family history of clinical signs and symptoms associated with CAPS  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This ranking applies to                   
all diseases in the CAPS spectrum OR 
only some diseases in the CAPS spectrum, please check all applicable  
 FCAS   FCAS/MWS   MWS  MWS/CINCA/NOMID   
CINCA/NOMID 
Q2 Characteristic of active disease 
1. Age at disease onset 
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This ranking applies to                   
all diseases in the CAPS spectrum OR 
only some diseases in the CAPS spectrum, please check all applicable  
 FCAS   FCAS/MWS   MWS  MWS/CINCA/NOMID   
CINCA/NOMID 
2. Episodic nature of symptoms 
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This ranking applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
3. Duration of episodes 
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
4. External triggers resulting in disease flares 
a) Cold-induced flares 
 
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
 
 
 
 
 
 
b) Stress-induced flares 
 
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant      relevant   relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
c)  Infection-induced flares 
 
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
Q3 Systemic clinical symptoms of active disease  
1. Fever 
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
 
 
2. Fatigue  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
3. Headaches  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
4. Irritability  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
 
 
 
Q4 Organ-specific clinical symptoms of active disease  
1. Eye manifestations  
a) Conjunctivitis  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
b) Keratitis  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
c) Uveitis  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
 
d) Papilledema and/or secondary optic nerve damage (atrophy, vision loss) 
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
2. Oral /ear-nose-throat (ENT) manifestations  
a)  Oral ulcers or aphtous stomatitis  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
b) Exudative  pharyngitis  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
 
 
c) Cervical lymphadenopathy  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
d) Sensorineural hearing loss  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
 
3. Chest manifestations  
a) Pleuritis / pericarditis / chest pain  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
 
4. Abdominal manifestations  
a)  Abdominal pain  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
b)  Splenomegaly  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
c)    Renal manifestations: proteinuria  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
  
 
d)    Renal manifestations: amyloidosis  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
5. Skin manifestations  
a) Urticaria-like rash  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
b) Maculo-papular rash  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
 
 
6. Musculoskeletal manifestations  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
b) Bone deformities (patella overgrowth, clubbing, frontal bossing)   
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
  
b) Growth retardation   
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
 
 
7. CNS manifestations   
a) Meningitis headaches / aseptic meningitis   
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
8. other manifestations, please specify   
a) ____________________________________   
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 b) ____________________________________   
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
Q5 Inflammatory markers  
a) Elevated CRP or SAA with clinical disease activity    
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
b) Elevated CRP or SAA without clinical disease activity in symptom free interval  
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
c) other: ____________________________________   
I consider this variable  not  oftennot  undecided  often  very  
   relevant  relevant    relevant  relevant  
            
 
This score applies to                   
 all diseases in the CAPS spectrumor    
only some diseases in the CAPS spectrum, pleasecheck all applicable 
 FCAS  FCAS/MWS overlap    MWS      MWS/CINCA/NOMID overlap  
CINCA/NOMID 
 
